The primary conclude point was the safety and tolerability of sifalimumab. Remedy-emergent adverse events (AEs) and significant AEs (SAEs) and their severity, end result, and any marriage towards the analyze medication ended up recorded by the investigator all through the review. AEs were being regarded as more likely to be https://dantewqfwk.howeweb.com/31444726/a-secret-weapon-for-nemifitide-ditfa